Evidence map›Paper›PMID 24375716›Full record

ArticleJournal of neuroscience research2014

Neuronal and nonneuronal COX-2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge.

Ying An, Natalya Belevych, Yufen Wang, Hao Zhang, Harvey Herschman, Qun Chen, Ning Quan

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Is cyclooxygenase-1 involved in neuroinflammation?Journal of neuroscience research · 2021
    Review
  4. Review
  5. Modulation of Neural Networks by Interleukin-1.Brain plasticity (Amsterdam, Netherlands) · 2021
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ying AnInstitute for Behavior Medicine Research, The Ohio State University, Columbus, Ohio; Department of Oral Biology, College of Dentistry, The Ohio State University, Columbus, Ohio.
Natalya Belevych
Yufen Wang
Hao Zhang
Harvey Herschman
Qun Chen
Ning Quan
Institute for Behavioral Medicine · US

Funding

IL-1R1 promoter complex in the neuroendocrine, nervous, and immune systemsR01AI076926 · NIAID · OHIO STATE UNIVERSITY · PI QUAN, NING · 2008 to 2012
$1.9M
NIAID NIH HHS R01 AI076926
6 · The paper itself

Abstract

Treating acute brain injuries with COX-2 inhibitors can produce both neuroprotective and neurotoxic effects. This study investigated the role of COX-2 in modulating acute brain injury induced by excitotoxic neural damage. Intrastriatal injection of excitotoxin (RS)-(tetrazole-5yl) glycine elicited COX-2 expression in two distinct groups of cells. cortical neurons surrounding the lesion and vascular cells in the lesion core. The vascular COX-2 was expressed in two cell types, endothelial cells and monocytes. Selective deletion of COX-2 in vascular cells in Tie2Cre Cox-2(flox/flox) mice did not affect the induction of COX-2 in neurons after the excitotoxin injection but resulted in increased lesion volume, indicating a neuroprotective role for the COX-2 expressed in the vascular cells. Selective deletion of monocyte COX-2 in LysMCre Cox-2(flox/flox) mice did not reduce COX-2-dependent neuroprotection, suggesting that endothelial COX-2 is sufficient to confer neuroprotection. Pharmacological inhibition of COX-2 activity in Tie2Cre Cox-2(flox/flox) mice reduced lesion volume, indicating a neurotoxic role for the COX-2 expressed in neurons. Furthermore, COX-2-dependent neurotoxicity was mediated, at least in part, via the activation of the EP1 receptor. These results show that Cox-2 expression induced in different cell types can confer opposite effects.

Indexed as

Analysis of VarianceAnimalsAntigens, DifferentiationCyclooxygenase 2Disease Models, AnimalGene Expression RegulationGlycineMiceMice, Inbred C57BLMice, KnockoutNeuronsNeuroprotective AgentsNeurotoxicity SyndromesNeurotoxinsN-MethylaspartatePhosphopyruvate HydrataseAntigens, DifferentiationCyclooxygenase 2Glycinemonocyte-macrophage differentiation antigenNeuroprotective AgentsNeurotoxinsN-MethylaspartatePhosphopyruvate HydratasePtgs2 protein, mouse(tetrazol-5-yl)glycineTetrazolesinflammationinjuryknockout mouse

Identifiers

PMID24375716
PMCPMC4085774
OpenAlexW1818110178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.